Company:  HARVARD BIOSCIENCE INC (HBIO)
Form Type:  10-Q
Filing Date:  11/8/2019 
CIK:  0001123494 
Address:  84 OCTOBER HILL RD 
City, State, Zip:  HOLLISTON, Massachusetts 01746 
Telephone:  (508) 893-8999 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$2.66  
Change: 
0.04 (1.53%)  
Trade Time: 
04:00 PM EST  
Market Cap: 
$102.09M
Trade HBIO now with 

© 2020  
Description of Business
Harvard Bioscience, Inc., a Delaware corporation, is a leading developer, manufacturer and seller of technologies, products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Our customers range from renowned academic institutions and government laboratories, to the world's leading pharmaceutical, biotechnology and clinical research organizations. With operations in North America and Europe, we sell through a combination of direct and distribution channels to customers around the world. Our History and Strategy Our business began in 1901 under the name Harvard Apparatus. It was founded by Dr. William T. Porter, a Professor of Physiology at Harvard Medical School and a pioneer of physiology education. We have grown over the years with the development and evolution of modern life science research and education. Our early inventions included ventilators based on Dr.
Register and access this filing in:     
  FORM 10-Q
    PART I. FINANCIAL INFORMATION
      Item 1. Financial Statements.
        BALANCE SHEET
        INCOME STATEMENT
        STOCKHOLDERS EQUITY
        CASH FLOW
        NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
      Item 2. Management's Discussion and Analysis of Financial ...
      FINANCIAL STATEMENTS
        CASH FLOW
      Item 3. Quantitative and Qualitative Disclosures about ...
      Item 4. Controls and Procedures.
    PART II. OTHER INFORMATION
      Item 1A. Risk Factors.
      Item 6. Exhibits
    SIGNATURES
    INDEX TO EXHIBITS
  EXHIBIT 31.1
    Certification
  EXHIBIT 31.2
    Certification
  EXHIBIT 32.1
    CERTIFICATION OF PERIODIC FINANCIAL REPORT
  EXHIBIT 32.2
    CERTIFICATION OF PERIODIC FINANCIAL REPORT